Advances in synthesis of novel annulated azecines and their unique pharmacological properties.

Anticancer agents Antipsychotic agents Aza-Claisen rearrangement Benzazecines Dopaminergic receptors ligands Ring-closing metathesis reactions

Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
21 Oct 2024
Historique:
received: 12 08 2024
revised: 26 09 2024
accepted: 05 10 2024
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 22 10 2024
Statut: aheadofprint

Résumé

Annulated azecines, mostly partially saturated benzo[d]azecine and dibenzo[c,g]azecine fusion isomers, constitute a unique class of alkaloids and nature-inspired azaheterocyclic compounds with interesting reactivity, physicochemical and biological properties. Due to difficulties associated with the synthesis of the benzazecine (or bioisosteric) scaffold they are not the focus of organic and medicinal chemists' consideration, whereas it is worth noting the range of their pharmacological activities and their potential application in medicinal chemistry. Herein, we reviewed the synthetic methodologies of arene-fused azecine derivatives known up to date and reported about the progress in disclosing their potential in drug discovery. Indeed, their conformational restriction or liberation drives their selectivity towards diverse biological targets, making them versatile scaffolds for developing drugs, including antipsychotic and anticancer drugs, but also small molecules with potential for anti-neurodegenerative treatments, as the recent literature shows.

Identifiants

pubmed: 39437575
pii: S0223-5234(24)00828-6
doi: 10.1016/j.ejmech.2024.116947
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

116947

Informations de copyright

Copyright © 2024. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of competing interest On behalf of all the co-authors, I declare that the authors of the manuscript entitled “Advances in synthesis of novel benzazecines and their unique pharmacological properties” have no competing interests to declare.

Auteurs

Anna V Listratova (AV)

Organic Chemistry Department, Рeoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation. Electronic address: listratova-av@rudn.ru.

Francesco Samarelli (F)

Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125, Bari, Italy. Electronic address: francesco.samarelli@uniba.it.

Alexander A Titov (AA)

Organic Chemistry Department, Рeoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation. Electronic address: titov-aa@rudn.ru.

Rosa Purgatorio (R)

Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125, Bari, Italy. Electronic address: rosa.purgatorio@uniba.it.

Modesto de Candia (M)

Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125, Bari, Italy. Electronic address: modesto.decandia@uniba.it.

Marco Catto (M)

Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125, Bari, Italy. Electronic address: marco.catto@uniba.it.

Alexey V Varlamov (AV)

Organic Chemistry Department, Рeoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation. Electronic address: varlamov-av@rudn.ru.

Leonid G Voskressensky (LG)

Organic Chemistry Department, Рeoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation. Electronic address: voskresenskiy-lg@rudn.ru.

Cosimo D Altomare (CD)

Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125, Bari, Italy. Electronic address: cosimodamiano.altomare@uniba.it.

Classifications MeSH